Clinical trial Recruiting at 1 site Interventional Ages 8 to 10

Using low-level red light to control myopia in children

Official title: An Exploratory Study on the Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression

Run by Shanghai Eye Disease Prevention and Treatment Center · NCT06717048 · Data updated 2026-11-12

This study is testing if low-level red light therapy can help slow down worsening eyesight in children aged 8-10 who have mild myopia.

Quick facts

Study typeInterventional
Ages8 Years to 10 Years
SexAll
Enrollment108 (estimated)
SponsorShanghai Eye Disease Prevention and Treatment Center
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedDecember 9, 2024
Main results expectedApril 9, 2025
Study endsJune 9, 2025
Registry record updatedDecember 4, 2024
Trial IDNCT06717048 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 8-10 years with low myopia, specifically those with spherical equivalent refractions ranging from -0.50 to -3.00 diopters.

Probably not a fit

Patients with secondary myopia, significant eye diseases, or systemic disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of Repeated Low-level Red-light (RLRL) therapy in controlling myopia progression in children aged 8-10 years with low myopia. The study aims to determine the optimal power and frequency of RLRL exposure and assess the rebound effect after discontinuation of treatment. Conducted as a prospective, double-blind, single-center, randomized controlled trial, it seeks to provide evidence for this innovative approach to myopia prevention and control. The trial addresses a significant public health concern, particularly in East Asia, where myopia is increasingly prevalent.

Why it matters

Potential benefit: If successful, this study could provide a non-invasive method to effectively manage and slow down myopia progression in children.

How similar studies have gone: While the use of RLRL for myopia control is a relatively novel approach, preliminary studies suggest potential effectiveness, warranting further investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age: 8-10 years old
2. Low myopia: cycloplegic spherical equivalent refractions (SERs) range from -0.50 (inclusive) to -3.00 diopters (D) and astigmatism less than -2.5 D in either eye.
3. signed informed consent and was able to participate in the study

Exclusion Criteria:

1. Secondary myopia, such as a history of retinopathy of prematurity or other neonatal diseases; syndromic myopia with a known genetic disorder or connective tissue disease, such as Stickler syndrome or Marfan syndrome
2. Strabismus or other binocular vision abnormalities
3. Cloudy refractive media: cloudy cornea, cataract or intraocular lens surgery
4. Eye diseases that affect retinal function: macular degeneration, diabetic retinopathy, retinal detachment, glaucoma or ocular hypertension, endophthalmitis, uveitis, optic neuropathy, etc.
5. History of refractive surgery, internal eye surgery, laser therapy, vitreous injection, etc.
6. diabetes, hypertension and other systemic disorders
7. History of use of retinal toxic drugs, such as hydroxychloroquine, etc.
8. Use of orthokeratology, atropine, multifocal frame glasses and other myopia control methods; children who are currently receiving atropine, orthokeratology, multifocal frame glasses and other myopia control treatment, can be enrolled after 2 weeks of treatment.
9. Other reasons considered unsuitable for inclusion by the study physician, including but not limited to other ocular and systemic disease abnormalities

Where it's running

  • Shanghai Eye Disease Prevention & Treatment Center
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.